Pathstone Holdings, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in PCVX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,387,911

-$190,704 QoQ

Shares Held

23,876

-12.1% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#151

of 329 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 87% Shared 2% None 11%

Healthcare · as of Jun 30, 2026

Pathstone Holdings, LLC holds $101,065,916 across 56 Biotechnology names. PCVX ranks #23 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,952	$22,825,735
2	REGN	Regeneron Pharmaceuticals, Inc.	13,825	$8,620,440
3	ASND	Ascendis Pharma A/S	20,248	$5,400,545
4	CYTK	Cytokinetics Inc	47,633	$4,057,854
5	JAZZ	Jazz Pharmaceuticals plc	15,152	$3,651,176
6	PTGX	Protagonist Therapeutics, Inc	28,187	$3,455,162
7	RPRX	Royalty Pharma plc	54,725	$3,068,429
8	ARGX	Argenx SE	3,094	$2,870,519

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,387,911	23,876	-12.1%	Shares	Defined	2026-08-13
2026-03-31	$1,578,615	27,166	+12.1%	Shares	Sole	2026-05-11
2025-12-31	$1,117,925	24,229	+9.7%	Shares	Sole	2026-02-13
2025-09-30	$795,644	22,089	+7.1%	Shares	Other	2025-11-13
2025-06-30	$670,680	20,630	-9.3%	Shares	Sole	2025-08-12
2025-03-31	$858,926	22,747	-27.9%	Shares	Sole	2025-05-15
2024-12-31	$2,581,944	31,541	+3.3%	Shares	Defined	2025-02-14
2024-09-30	$3,488,319	30,527	+7.6%	Shares	Sole	2024-11-07
2024-06-30	$2,142,444	28,373	+21.9%	Shares	Defined	2024-08-14
2024-03-31	$1,589,777	23,273	+519.5%	Shares	Sole	2024-05-13
2023-12-31	$235,939	3,757	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.